Growth Metrics

Eledon Pharmaceuticals (ELDN) Change in Accured Expenses (2013 - 2022)

Eledon Pharmaceuticals posted quarterly Change in Accured Expenses of $210000.0 for Q4 2022, up 28.83% year-on-year from $163000.0 in Q4 2021, and down 92.79% on a QoQ basis from $2.9 million in Q3 2022.

Eledon Pharmaceuticals (ELDN) has 10 years of Change in Accured Expenses data on file, last reported at $210000.0 in Q4 2022.

  • For the quarter ending Q4 2022, Change in Accured Expenses rose 28.83% year-over-year to $210000.0; the trailing twelve-month figure through Dec 2022 stood at $2.1 million (down 2.89% YoY), and the FY2022 full-year result was $2.1 million, down 2.89% from the prior year.
  • Change in Accured Expenses for Q4 2022 stood at $210000.0, down from $2.9 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $4.2 million in Q3 2020 and bottomed at -$4.0 million in Q4 2020.
  • The 5-year median for Change in Accured Expenses is $171000.0 (2018), against an average of $194350.0.
  • Peak annual rise in Change in Accured Expenses reached 1558.42% in 2020, while the deepest fall reached 1084.21% in 2020.
  • A 5-year view of Change in Accured Expenses shows it stood at $931000.0 in 2018, then sank by 136.73% to -$342000.0 in 2019, then slumped by 1084.21% to -$4.0 million in 2020, then jumped by 104.02% to $163000.0 in 2021, then increased by 28.83% to $210000.0 in 2022.
  • The last three Change in Accured Expenses figures came in at $210000.0 (Q4 2022), $2.9 million (Q3 2022), and $359000.0 (Q2 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 931,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -176.03 Mn
10 Eledon Pharmaceuticals 419.90 Mn 203.87 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 210,000.00
Dec 31, 2022 210,000.00
Sep 30, 2022 2.91 Mn
Sep 30, 2022 2.91 Mn
Jun 30, 2022 359,000.00
Jun 30, 2022 359,000.00
Mar 31, 2022 -1.40 Mn
Mar 31, 2022 -1.40 Mn
Dec 31, 2021 163,000.00
Dec 31, 2021 163,000.00
Sep 30, 2021 1.37 Mn
Sep 30, 2021 1.37 Mn
Jun 30, 2021 -1.61 Mn
Jun 30, 2021 -1.61 Mn
Mar 31, 2021 2.22 Mn
Mar 31, 2021 2.22 Mn
Dec 31, 2020 -4.05 Mn
Dec 31, 2020 -4.05 Mn
Sep 30, 2020 4.24 Mn
Sep 30, 2020 4.24 Mn
Jun 30, 2020 -785,000.00
Jun 30, 2020 -785,000.00
Mar 31, 2020 552,000.00
Mar 31, 2020 552,000.00
Dec 31, 2019 -342,000.00
Dec 31, 2019 -342,000.00
Sep 30, 2019 -291,000.00
Sep 30, 2019 -291,000.00
Jun 30, 2019 -1.30 Mn
Jun 30, 2019 -1.30 Mn
Mar 31, 2019 537,000.00
Mar 31, 2019 537,000.00
Dec 31, 2018 931,000.00
Dec 31, 2018 931,000.00
Sep 30, 2018 151,000.00
Sep 30, 2018 151,000.00
Jun 30, 2018 -167,000.00
Jun 30, 2018 -167,000.00
Mar 31, 2018 179,000.00
Mar 31, 2018 179,000.00
Dec 31, 2017 -960,000.00
Dec 31, 2017 -960,000.00
Sep 30, 2017 -1.01 Mn
Sep 30, 2017 -1.01 Mn
Jun 30, 2017 -368,000.00
Jun 30, 2017 -368,000.00
Mar 31, 2017 375,000.00
Mar 31, 2017 375,000.00
Dec 31, 2016 153,000.00
Dec 31, 2016 153,000.00
Sep 30, 2016 -11,000.00
Sep 30, 2016 -11,000.00
Jun 30, 2016 456,000.00
Jun 30, 2016 456,000.00
Mar 31, 2016 -663,000.00
Mar 31, 2016 -663,000.00
Dec 31, 2015 1.43 Mn
Dec 31, 2015 1.43 Mn
Sep 30, 2015 38,000.00
Sep 30, 2015 38,000.00
Jun 30, 2015 1.17 Mn
Jun 30, 2015 1.17 Mn
Mar 31, 2015 -1.16 Mn
Mar 31, 2015 -1.16 Mn
Dec 31, 2014 1.30 Mn
Dec 31, 2014 1.30 Mn
Sep 30, 2014 20,000.00
Sep 30, 2014 20,000.00
Jun 30, 2014 389,000.00
Jun 30, 2014 389,000.00
Mar 31, 2014 -432,000.00
Mar 31, 2014 -432,000.00
Dec 31, 2013 -464,000.00
Dec 31, 2013 -464,000.00